GE HealthCare announced that it will acquire Intelerad, a medical imaging software provider, for $2.3 billion in cash. This acquisition marks another significant move in this week’s wave of medtech deals, following Abbott’s bid for Exact Sciences and Solventum’s purchase of Acera Surgical.
The deal is expected to close in the first half of 2026, expanding GE HealthCare’s presence from inpatient facilities into outpatient and ambulatory care settings.
Expanding Outpatient and Ambulatory Care
Intelerad specializes in imaging software for hospitals and outpatient networks. By acquiring the company, GE HealthCare will strengthen its portfolio with cloud-enabled and intelligent solutions in radiology and cardiology.
“As hospital and ambulatory care providers face increasing demand for imaging and rising patient volumes, they are seeking to simplify and unify workflows,” said GE HealthCare CEO Peter Arduini. “Our acquisition of Intelerad will enhance our capabilities in outpatient networks, allowing care teams to operate more efficiently, improve outcomes, and deliver precision care globally.”
Revenue Projections and Growth Potential
GE HealthCare forecasts that Intelerad will generate approximately $270 million in revenue in the first full year after the acquisition, with roughly 90% of this revenue recurring. Intelerad’s revenue has been growing at a low-double-digit rate annually and is expected to accelerate under GE HealthCare’s ownership.
According to the announcement, the acquisition positions GE HealthCare to tap into the outpatient enterprise imaging market, which exceeds $2 billion. Additionally, the increasing global adoption of cloud services, the shift of procedures to outpatient settings, and rising demand for integrated solutions are driving double-digit growth in cloud-based and cloud-native solutions.
Analyst Reactions
As per MedTechDive, analysts view the acquisition positively. J.P. Morgan’s Robbie Marcus described the deal as a “solid tuck-in” that supports GE HealthCare’s strategic move toward recurring revenue sources. He added that the combined company will offer a wider range of cloud-enabled and AI-powered imaging solutions across both academic medical centers and ambulatory networks.
Stifel analyst Rick Wise echoed this sentiment. He noted that Intelerad enhances GE HealthCare’s digital offerings and expands its footprint in a fast-growing market. He added that the acquisition promises immediate growth and margin benefits.
Meanwhile, BTIG analyst Ryan Zimmerman highlighted that Intelerad products could integrate into larger “enterprise-wide transactions” for equipment and software. He added that pairing GE HealthCare’s internally developed AI algorithms with Intelerad’s software may accelerate adoption across imaging networks.
Part of a Busy Week for Medtech M&A
This proposed acquisition represents the third major medtech deal announced this week. Earlier, Abbott proposed to buy Exact Sciences for about $21 billion, while Solventum agreed to acquire Acera Surgical. GE HealthCare’s purchase of Intelerad signals its strategic commitment to expand in outpatient care and digital imaging solutions.